PURE Bioscience (PURE) Short Interest Ratio & Short Volume $0.09 0.00 (-2.67%) As of 09:38 AM Eastern Add Compare Share Share Short Interest Stock AnalysisChartEarningsHeadlinesSEC FilingsShort InterestBuy This Stock PURE Bioscience Short Interest DataPURE Bioscience (PURE) has a short interest of 20,500 shares, representing 0.03% of the float (the number of shares available for trading by the public). This marks a -1.44% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.4, indicating that it would take 0.4 days of the average trading volume of 56,943 shares to cover all short positions.Current Short Interest20,500 sharesPrevious Short Interest20,800 sharesChange Vs. Previous Month-1.44%Dollar Volume Sold Short$1.70 thousandShort Interest Ratio0.4 Days to CoverLast Record DateJune 15, 2025Outstanding Shares111,890,000 sharesShort Percent of Float0.03%Today's Trading Volume2,125 sharesAverage Trading Volume56,943 sharesToday's Volume Vs. Average4% Short Selling PURE Bioscience? Sign up to receive the latest short interest report for PURE Bioscience and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartPURE Short Interest Over TimePURE Days to Cover Over TimePURE Percentage of Float Shorted Over Time PURE Bioscience Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 6/15/202520,500 shares $1.70 thousand -1.4%0.0%0.4 $0.08 5/31/202520,800 shares $2.04 thousand -88.9%0.0%0.1 $0.10 5/15/2025187,700 shares $12.56 thousand +1,250.4%0.3%1.8 $0.07 4/30/202513,900 shares $835.39 +6.9%N/A0.2 $0.06 4/15/202513,000 shares $804.70 -34.3%0.0%0.1 $0.06 3/31/202519,800 shares $1.85 thousand +2,100.0%0.0%0.1 $0.09 3/15/2025900 shares $61.92 +50.0%0.0%0 $0.07 2/28/2025600 shares $36.00 -98.3%0.0%0 $0.06 2/15/202536,200 shares $2.53 thousand +1,710.0%0.1%1 $0.07 1/31/20252,000 shares $144.00 -93.1%N/A0 $0.07 Get the Latest News and Ratings for PURE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for PURE Bioscience and its competitors with MarketBeat's FREE daily newsletter. 1/15/202529,100 shares $2.18 thousand +561.4%N/A0.1 $0.08 12/31/20244,400 shares $280.72 +1,000.0%N/A0 $0.06 12/15/2024400 shares $28.00 No ChangeN/A0 $0.07 11/30/2024400 shares $36.00 -97.2%N/A0 $0.09 11/15/202414,500 shares $2.28 thousand -68.9%N/A0.2 $0.16 10/31/202446,600 shares $4.38 thousand +50.8%N/A0.9 $0.09 10/15/202430,900 shares $2.07 thousand -47.2%N/A1.3 $0.07 9/30/202458,500 shares $4.45 thousand +181.3%N/A0.9 $0.08 9/15/202420,800 shares $1.66 thousand -30.7%N/A0.5 $0.08 8/31/202430,000 shares $1.89 thousand -61.2%N/A0.6 $0.06 8/15/202477,300 shares $4.81 thousand -18.7%N/A4.9 $0.06 7/31/202495,100 shares $7.59 thousand +397.9%N/A1.5 $0.08 7/15/202419,100 shares $1.25 thousand No ChangeN/A1 $0.07 6/30/202419,100 shares $1.18 thousand No ChangeN/A0.5 $0.06 6/15/202419,100 shares $1.24 thousand -48.8%N/A0.2 $0.07 5/31/202437,300 shares $2.82 thousand +532.2%N/A1 $0.08 5/15/20245,900 shares $526.87 -1.7%N/A0.2 $0.09 4/30/20246,000 shares $426.00 +122.2%N/A0.1 $0.07 4/15/20242,700 shares $206.82 +575.0%N/A0 $0.08 3/31/2024400 shares $39.60 No ChangeN/A0 $0.10 3/15/2024400 shares $36.00 -97.7%N/A0 $0.09 2/29/202417,200 shares $1.89 thousand -37.9%N/A1 $0.11 2/15/202427,700 shares $2.96 thousand +3,362.5%N/A0.3 $0.11 1/15/20241,700 shares $213.01 +325.0%N/A0 $0.13 12/31/2023400 shares $51.86 -97.2%N/A0 $0.13 12/15/202314,300 shares $2.15 thousand +2,760.0%N/A0.1 $0.15 11/30/2023500 shares $59.00 -44.4%N/A0 $0.12 11/15/2023900 shares $92.97 +125.0%N/A0 $0.10 10/31/2023400 shares $32.40 No ChangeN/A0 $0.08 10/15/2023400 shares $47.20 -94.0%N/A0 $0.12A grave, grave error. (Ad)Famed financial analyst, Porter Stansberry, calls this technology “The Final Frontier” because it holds the key to unlocking technological breakthroughs we once thought were impossible. And it may just be the only thing capable of bringing America back from the brink of recession – despite Washington’s incompetence and addiction to reckless spending. That’s why Elon Musk, Jeff Bezos, Jensen Huang, and even Bill Gates are pouring billions into the infrastructure behind it.They know what’s coming. 9/30/20236,700 shares $743.70 -10.7%N/A0.1 $0.11 9/15/20237,500 shares $757.50 -61.9%N/A0.1 $0.10 8/31/202319,700 shares $2.07 thousand -36.9%N/A0.4 $0.11 8/15/202331,200 shares $3.74 thousand +766.7%N/A0.6 $0.12 7/31/20233,600 shares $306.00 -25.0%N/A0.4 $0.09 7/15/20234,800 shares $528.00 +500.0%N/A0.1 $0.11 6/30/2023800 shares $63.92 +100.0%N/A0 $0.08 6/15/2023400 shares $35.85 No ChangeN/A0 $0.09 5/31/2023400 shares $44.40 -93.1%N/A0 $0.11 5/15/20235,800 shares $640.90 -55.0%N/A0.2 $0.11 4/30/202312,900 shares $1.16 thousand +101.6%N/A0.1 $0.09 4/15/20236,400 shares $640.00 -14.7%N/A0 $0.10 3/31/20237,500 shares $1.15 thousand +368.8%N/A0.1 $0.15 3/15/20231,600 shares $228.32 -90.0%N/A0 $0.14 2/28/202316,000 shares $2.16 thousand +3,900.0%N/A0.3 $0.14 2/15/2023400 shares $56.00 -96.2%N/A0 $0.14 1/31/202310,600 shares $1.38 thousand +715.4%N/A0.3 $0.13 1/15/20231,300 shares $130.00 +225.0%N/A0 $0.10 12/30/2022400 shares $33.92 -93.8%N/A0 $0.08 12/15/20226,400 shares $851.84 -65.6%N/A0.1 $0.13 11/30/202218,600 shares $2.79 thousand +463.6%N/A0.1 $0.15 11/15/20223,300 shares $561.50 -88.5%N/A0.1 $0.17 10/31/202228,600 shares $4.81 thousand +5.9%N/A0.3 $0.17 10/15/202227,000 shares $5.21 thousand +23.9%N/A1.9 $0.19 9/30/202221,800 shares $4.36 thousand +1.4%N/A0.2 $0.20 9/15/202221,500 shares $4.94 thousand -40.9%N/A0 $0.23 8/31/202236,400 shares $7.28 thousand +23.0%N/A0.2 $0.20 8/15/202229,600 shares $6.81 thousand -1.3%N/A0.2 $0.23 7/31/202230,000 shares $5.99 thousand +226.1%N/A0.1 $0.20 7/15/20229,200 shares $1.84 thousand -72.0%N/A0.2 $0.20 6/30/202232,900 shares $6.25 thousand -23.3%N/A0.7 $0.19 6/15/202242,900 shares $8.26 thousand -3.2%N/A1.7 $0.19 5/31/202244,300 shares $8.86 thousand +23.7%N/A0.9 $0.20 5/15/202235,800 shares $6.80 thousand +1,093.3%N/A0.7 $0.19 4/30/20223,000 shares $524.40 -67.4%N/A0.1 $0.17 4/15/20229,200 shares $1.77 thousand -75.7%N/A0.1 $0.19 3/31/202237,800 shares $7.18 thousand +1,045.5%N/A0.3 $0.19 3/15/20223,300 shares $595.65 -83.8%N/A0.1 $0.18 2/28/202220,400 shares $3.97 thousand +100.0%N/A1.4 $0.19 2/15/202210,200 shares $2.04 thousand +108.2%N/A0.1 $0.20 1/31/20224,900 shares $1.08 thousand +2.1%N/A0.1 $0.22 1/15/20224,800 shares $962.40 +50.0%N/A0 $0.20 12/31/20213,200 shares $610.24 -93.9%N/A0 $0.19 12/15/202152,300 shares $14.29 thousand +325.2%N/A0.4 $0.27 11/30/202112,300 shares $4.06 thousand +200.0%N/A0.1 $0.33 11/15/20214,100 shares $1.31 thousand -70.1%N/A0 $0.32 10/29/202113,700 shares $5.21 thousand +291.4%N/A0.2 $0.38 10/15/20213,500 shares $1.17 thousand -7.9%N/A0.1 $0.34 9/30/20213,800 shares $1.49 thousand -86.9%N/A0.1 $0.39 9/15/202129,100 shares $12.24 thousand +419.6%N/A0.2 $0.42A grave, grave error. (Ad)Famed financial analyst, Porter Stansberry, calls this technology “The Final Frontier” because it holds the key to unlocking technological breakthroughs we once thought were impossible. And it may just be the only thing capable of bringing America back from the brink of recession – despite Washington’s incompetence and addiction to reckless spending. That’s why Elon Musk, Jeff Bezos, Jensen Huang, and even Bill Gates are pouring billions into the infrastructure behind it.They know what’s coming. 8/31/20215,600 shares $2.02 thousand -11.1%N/A0 $0.36 8/13/20216,300 shares $2.39 thousand +152.0%N/A0.2 $0.38 7/30/20212,500 shares $1.05 thousand No ChangeN/A0.1 $0.42 7/15/20212,500 shares $1.10 thousand -30.6%N/A0.1 $0.44 6/30/20213,600 shares $1.64 thousand +28.6%N/A0 $0.46 6/15/20212,800 shares $1.34 thousand -6.7%N/A0.1 $0.48 5/28/20213,000 shares $1.53 thousand +25.0%N/A0 $0.51 5/14/20212,400 shares $1.49 thousand No ChangeN/A0 $0.62 4/30/20212,400 shares $1.49 thousand +50.0%N/A0.1 $0.62 4/15/20211,600 shares $1.12 thousand No ChangeN/A0 $0.70 3/31/20211,600 shares $1.16 thousand -63.6%N/A0 $0.73 3/15/20214,400 shares $3.12 thousand +7.3%N/A0 $0.71 2/26/20214,100 shares $3.20 thousand -46.8%N/A0.1 $0.78 2/12/20217,700 shares $6.01 thousand +57.1%N/A0.1 $0.78 1/29/20214,900 shares $3.72 thousand -71.8%N/A0.1 $0.76 1/15/202111,600 shares $9.63 thousand -4.1%N/A0.1 $0.83 12/31/202023,500 shares $21.15 thousand +102.6%N/A0.1 $0.90 12/15/202011,600 shares $10.56 thousand -4.1%N/A0.1 $0.91 11/30/202012,100 shares $12.83 thousand +26.0%N/A0.2 $1.06 11/15/20209,600 shares $12.48 thousand +5.5%N/A0.1 $1.30 10/30/20209,100 shares $12.10 thousand -15.0%N/A0.2 $1.33 10/15/202010,700 shares $14.98 thousand -60.8%N/A0.1 $1.40 9/30/202027,300 shares $46.66 thousand +58.7%N/A0.3 $1.71 9/15/202017,200 shares $25.80 thousand -45.4%N/A0.2 $1.50 8/31/202031,500 shares $47.25 thousand -15.3%N/A0.4 $1.50 8/14/202037,200 shares $56.54 thousand +4.2%N/A0.4 $1.52 7/31/202035,700 shares $51.05 thousand +21.4%N/A0.2 $1.43 7/15/202029,400 shares $39.25 thousand -45.5%N/A0.1 $1.34 PURE Short Interest - Frequently Asked Questions What is PURE Bioscience's current short interest? Short interest is the volume of PURE Bioscience shares that have been sold short but have not yet been closed out or covered. As of June 15th, investors have sold 20,500 shares of PURE short. 0.03% of PURE Bioscience's shares are currently sold short. Learn More on PURE Bioscience's current short interest. What is a good short interest percentage for PURE Bioscience? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.03% of PURE Bioscience's floating shares are currently sold short. Is PURE Bioscience's short interest increasing or decreasing? PURE Bioscience saw a decline in short interest during the month of June. As of June 15th, there was short interest totaling 20,500 shares, a decline of 1.4% from the previous total of 20,800 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does PURE Bioscience's short interest compare to its competitors? 0.03% of PURE Bioscience's shares are currently sold short. Here is how the short interest of companies in the industry of "chemicals" compare to PURE Bioscience: TOMI Environmental Solutions, Inc. (0.29%), Solarwindow Technologies, Inc. (1.07%), Bion Environmental Technologies Inc. (0.00%), Gulf Resources, Inc. (3.57%), CN Energy Group. Inc. (2.09%), Evogene Ltd. (7.54%), Senestech, Inc. (19.90%), N2OFF, Inc. (2.15%), TOR Minerals International Inc (0.06%), Danimer Scientific, Inc. (11.97%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($69.26 billion), Invesco QQQ ($25.22 billion), iShares Russell 2000 ETF ($20.33 billion), iShares 20+ Year Treasury Bond ETF ($9.99 billion), MicroStrategy Incorporated ($9.12 billion), Canadian Natural Resources Limited ($6.73 billion), SPDR S&P Biotech ETF ($6.52 billion), Invesco S&P 500 Equal Weight ETF ($5.60 billion), Financial Select Sector SPDR Fund ($4.64 billion), and iShares iBoxx $ Investment Grade Corporate Bond ETF ($4.59 billion). View all of the most shorted stocks. What does it mean to sell short PURE Bioscience stock? Short selling PURE is an investing strategy that aims to generate trading profit from PURE Bioscience as its price is falling. PURE shares are trading down $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against PURE Bioscience? A short squeeze for PURE Bioscience occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of PURE, which in turn drives the price of the stock up even further. How often is PURE Bioscience's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including PURE, twice per month. The most recent reporting period available is June, 15 2025. More Short Interest Resources from MarketBeat Related Companies TOMZ Short Squeeze WNDW Short Squeeze BNET Short Squeeze GURE Short Squeeze CNEY Short Squeeze EVGN Short Squeeze SNES Short Squeeze NITO Short Squeeze TORM Short Squeeze DNMR Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:PURE) was last updated on 7/1/2025 by MarketBeat.com Staff From Our PartnersThis Crypto Is Set to Explode in JanuaryFree summit: How to profit from the Coinbase-Deribit deal Our hedge fund experts know exactly what this mea...Crypto 101 Media | SponsoredTrump set to Boost Social Security Checks by 400%?If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredHow to Collect Up To $5,917/mo From Trump’s Made In USA BoomHow to Collect Up To $5,917/mo From Trump's Made In USA Boom Thanks to President Trump's America-First poli...Investors Alley | SponsoredGold prediction: $5,000/oz. or higher is comingThe perfect gold play right now? (currently under $10) Everything in the news now lines up perfectly for an...Stansberry Research | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PURE Bioscience Please log in to your account or sign up in order to add this asset to your watchlist. Share PURE Bioscience With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PURE Stock Alerts